Fig. 3 | Scientific Reports

Fig. 3

From: Effects of rice bran arabinoxylan compound on quality of life of cancer patients during active treatment: a randomised placebo-controlled pilot trial

Fig. 3

Plots showing the relative treatment effects (RTE with 95% confidence interval) between RBAC and placebo groups in terms of role functioning (RF2), social functioning (SF), cognitive functioning (CF), financial difficulties (FI), fatigue (FA), pain (PA), dyspnoea (DY) and appetite loss (AP) over time. Significant difference*p ≤ 0.05,**p ≤ 0.01 and marginally + p ≈ 0.05. RBAC = rice bran arabinoxylan compound.

Back to article page